These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 5524271)

  • 21. Monoamine oxidase activity in peripheral organs and adrenergic tissues of the rat.
    Klingman GI; Klingman JD
    Biochem Pharmacol; 1966 Jan; 15(1):77-91. PubMed ID: 5949406
    [No Abstract]   [Full Text] [Related]  

  • 22. The nature of inhibition of thyroid monoamine oxidase by thyroxine in rat thyroid.
    Knopp J
    Endokrinologie; 1982 Nov; 80(3):367-70. PubMed ID: 7166166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of monoamine oxidase inhibitors and some related compounds on lipid metabolism in rat. Plasma free fatty acids and lipoprotein lipase of the heart and adipose tissue.
    Mattila M; Torsti P
    Ann Med Exp Biol Fenn; 1966; 44(3):397-400. PubMed ID: 4382354
    [No Abstract]   [Full Text] [Related]  

  • 24. Increased monoamine oxidase activity produced by general inhalation anesthetic agents.
    Schneider DR; Harris SG; Gardier RW; O'Neill JJ; Delaunois AL
    Arch Int Pharmacodyn Ther; 1974 Sep; 211(1):64-73. PubMed ID: 4460913
    [No Abstract]   [Full Text] [Related]  

  • 25. Metaraminol and monoamineoxidase activity in the rat heart.
    Bareggi SR; Carminati P; Manara L
    Res Commun Chem Pathol Pharmacol; 1971 May; 2(3):347-54. PubMed ID: 5149892
    [No Abstract]   [Full Text] [Related]  

  • 26. Inhibition by pargyline of cardiovascular amine oxidase activity.
    Fuentes JA; Neff NH
    Biochem Pharmacol; 1977 Nov; 26(22):2107-12. PubMed ID: 588291
    [No Abstract]   [Full Text] [Related]  

  • 27. Recovery from amnesia induced by pre-test injections of monoamine oxidase inhibitors.
    Botwinick CY; Quartermain D
    Pharmacol Biochem Behav; 1974 May; 2(3):375-9. PubMed ID: 4858168
    [No Abstract]   [Full Text] [Related]  

  • 28. Rat brain monoamine oxidase inhibition by beta-diethylaminoethyl diphenylprophylacetate (SKF-525A).
    Pfeffer M; Semmel M; Schor JM
    Enzymologia; 1968 Jul; 34(5):299-303. PubMed ID: 5672567
    [No Abstract]   [Full Text] [Related]  

  • 29. Studies on the nature of the increased monoamine oxidase activity in the rat heart after adrenalectomy.
    Callingham BA; Laverty R
    J Pharm Pharmacol; 1973 Dec; 25(12):940-7. PubMed ID: 4150296
    [No Abstract]   [Full Text] [Related]  

  • 30. The labeling in vivo of monoamine oxidase by 14 C-pargyline: a tool for studying the synthesis of the enzyme.
    Erwin VG; Deitrich RA
    Mol Pharmacol; 1971 Mar; 7(2):219-28. PubMed ID: 5125856
    [No Abstract]   [Full Text] [Related]  

  • 31. [Succinate dehydrogenase activity in various parts of the rat heart in systole and diastole].
    Rakhmetov AS
    Arkh Anat Gistol Embriol; 1986 Nov; 91(11):23-5. PubMed ID: 3813905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Selective inhibition of monoamine oxidase.
    Fuller RW
    Adv Biochem Psychopharmacol; 1972; 5():339-54. PubMed ID: 4559891
    [No Abstract]   [Full Text] [Related]  

  • 33. [Monoamine oxidase and its inhibition (author's transl)].
    Gérardy J
    J Pharm Belg; 1980; 35(2):133-42. PubMed ID: 7391926
    [No Abstract]   [Full Text] [Related]  

  • 34. Detection of monoamine oxidase a in brain of living rats with [18F]fluoroethyl-harmol PET.
    Cumming P; Skaper D; Kuwert T; Maschauer S; Prante O
    Synapse; 2015 Jan; 69(1):57-9. PubMed ID: 25229748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monoamine oxidase-III. Further studies of inhibition by propargylamines.
    Williams CH; Lawson J
    Biochem Pharmacol; 1975 Oct; 24(20):1889-91. PubMed ID: 1191339
    [No Abstract]   [Full Text] [Related]  

  • 36. Ontogenetic development of monoamine oxidase.
    Eiduson S
    Adv Biochem Psychopharmacol; 1972; 5():271-87. PubMed ID: 4559889
    [No Abstract]   [Full Text] [Related]  

  • 37. [Selective inhibition by pargyline and phenelzine of oxidation of biogenic amines in vivo].
    Romanova LA; Gorkin VZ
    Farmakol Toksikol; 1969; 32(6):667-9. PubMed ID: 5381595
    [No Abstract]   [Full Text] [Related]  

  • 38. Molecular and kinetic characterization of monoamine oxidases in the rat heart.
    Guimarães JT; Vindis C; Soares-da-Silva P; Parini A
    Biochem Soc Trans; 1998 Nov; 26(4):S392. PubMed ID: 10047906
    [No Abstract]   [Full Text] [Related]  

  • 39. Mitochondrial monoamine oxidase. Inactivation by pargyline. Adduct formation.
    Chuang HY; Patek DR; Hellerman L
    J Biol Chem; 1974 Apr; 249(8):2381-4. PubMed ID: 4822497
    [No Abstract]   [Full Text] [Related]  

  • 40. D-amphetamine-induced hydrogen peroxide production in skeletal muscle is modulated by monoamine oxidase inhibition.
    Duarte JA; Carvalho F; Fernandes E; Remião F; Bastos ML; Magalhães J; Appell HJ
    Int J Sports Med; 2004 Aug; 25(6):446-9. PubMed ID: 15346233
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.